Abstract

Mercury is an extremely dangerous environmental contaminant responsible for episodes of human intoxication throughout the world. Methylmercury, the most toxic compound of this metal, mainly targets the central nervous system, accumulating preferentially in cells of glial origin and causing oxidative stress. Despite studies demonstrating the current exposure of human populations, the consequences of mercury intoxication and concomitant use of drugs targeting the central nervous system (especially drugs used in long-term treatments, such as analgesics) are completely unknown. Morphine is a major option for pain management; its global consumption more than quadrupled in the last decade. Controversially, morphine has been proposed to function in oxidative stress independent of the activation of the opioid receptors. In this work, a therapeutic concentration of morphine partially protected the cellular viability of cells from a C6 glioma cell line exposed to methylmercury. Morphine treatment also reduced lipid peroxidation and totally prevented increases in nitrite levels in those cells. A mechanistic study revealed no alteration in sulfhydryl groups or direct scavenging at this opioid concentration. Interestingly, the opioid antagonist naloxone completely eliminated the protective effect of morphine against methylmercury intoxication, pointing to opioid receptors as the major contributor to this action. Taken together, the experiments in the current study provide the first demonstration that a therapeutic concentration of morphine is able to reduce methylmercury-induced oxidative damage and cell death by activating the opioid receptors. Thus, these receptors may be a promising pharmacological target for modulating the deleterious effects of mercury intoxication. Although additional studies are necessary, our results support the clinical safety of using this opioid in methylmercury-intoxicated patients, suggesting that normal analgesic doses could confer an additional degree of protection against the cytotoxicity of this xenobiotic.

Highlights

  • IntroductionMethylmercury (MeHg), the most toxic compound of this metal, crosses biological membranes and tends to accumulate in tissues [1,2]

  • This work provides the first demonstration that a therapeutic concentration of morphine partially avoids the loss of cellular viability (Figure 2) and completely prevents the increase of nitrite levels (Figure 3) observed after exposure of glioma cells to MeHg

  • The initial deleterious events observed in mercury poisoning are related to imbalances in glial cells; oxidative stress plays a crucial role in cell damage and death [13,14]

Read more

Summary

Introduction

Methylmercury (MeHg), the most toxic compound of this metal, crosses biological membranes and tends to accumulate in tissues [1,2]. This characteristic causes MeHg to bioaccumulate through the food chain, with the highest concentrations found in human populations, leading to the mercury intoxication events that have been observed throughout the world, for example in Japan, Seychelles, and the Amazon [3,4,5]. In the Amazon, environmental and human epidemiological studies demonstrated the chronic exposure of populations to this metal and revealed that the present levels of MeHg exceed the safety limits recommended by the World Health Organization [3,6]. A previous study revealed a key role for astrocytes in mediating MeHg neurotoxicity via accumulating MeHg and participating in the inhibition of neurotransmitters and the transport of metabolites, among other actions [13]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call